P. Mikus et T. Ny, INTRACELLULAR POLYMERIZATION OF THE SERPIN PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2, The Journal of biological chemistry, 271(17), 1996, pp. 10048-10053
Plasminogen activator inhibitor type 2 (PAI-2) is synthesized in two m
olecular forms: an intracellular, nonglycosylated form and an extracel
lular, glycosylated form. The bitopological distribution of PAI-2 is c
aused by an inefficient internal secretion signal. In addition, the se
cretion efficiency of PAI-2 seems to differ, depending on the cell typ
e, differentiation state, and culture conditions. In recombinant cell
clones designed for the synthesis of the secreted form of PAI-2, the f
raction of secreted PAI-2 decreased with increasing expression levels.
Subcellular fractionation of cell clones with higher expression level
s revealed that PAI-2 accumulating in the cell was mainly associated w
ith the organelles of the secretory pathway. Electrophoresis under non
denaturating conditions revealed that the PAI-2 retained at higher exp
ression levels was mainly polymerized. Polymers of PAI-2 were also det
ected in cytosolic extracts prepared from human placenta and phorbol e
ster-stimulated U 937 cells, indicating that intracellular polymerizat
ion of PAI-2 may occur in the cytosols of cells that normally express
PAI-2 under physiological conditions. When purified PAI-2 or cellular
extracts were incubated at 37 degrees C for 24 h most of the PAI-2 pro
tein was found to polymerize. Polymer formation was prevented by the a
ddition of synthetic peptides with sequences corresponding to residues
P2 to P14 in the reactive center loop of PAI-2 and antithrombin. Thes
e synthetic peptides also caused dissociation of prepolymerized purifi
ed PAI-2 and PAI-2 polymers in cellular extracts. Incubation with unre
lated peptides of the same size had no effect on polymer formation or
dissociation of preformed polymers, indicating that polymerization of
PAI-2 occurs by the loop-sheet mechanism. Taken together, our data sug
gest that the wild-type form of PAI-2, like some natural pathological
genetic variants of alpha(1)-antitrypsin, antithrombin, and C1 inhibit
or readily polymerizes intracellularly and that polymerization may lea
d to a reduced secretion efficiency.